Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for PAVmed Inc. (PAVM : NSDQ)

• Company Description    PAVmed Inc. is a medical device company. Its diversified pipeline of products address unmet clinical needs, which consists of CarpX (TM) to treat carpal tunnel syndrome; NextFlo(TM) and NextCath(TM) a disposable infusion pump; PortIO(TM) and NextCath interventional radiology and Caldus (TM) tissue ablation and cardiovascular intervention. PAVmed Inc. is headquartered in New York City. Number of Employees: 41

• Price / Volume Information    Yesterday's Closing Price: $6.39 Daily Weekly Monthly 20 Day Moving Average: 15,859 shares Shares Outstanding: 1.00 (millions) Market Capitalization: $6.36 (millions) Beta: 0.64 52 Week High: $20.70 52 Week Low: $6.00 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -30.32% -33.72% 12 Week -37.41% -42.14% Year To Date -3.63% -11.95%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 360 MADISON AVENUE 25TH FLOOR - NEW YORK,NY 10017 USA ph: 917-813-1828 fax: - mjr@pavmed.com http://www.pavmed.com

• General Corporate Information    Officers Lishan Aklog - Chief Executive Officer;Chairman of the Board of D Michael J. Glennon - Vice Chairman Dennis M. McGrath - Chief Financial Officer;President Debra J. White - Director Timothy Baxter - Director Peer Information PAVmed Inc. (ABMD) PAVmed Inc. (DMDS) PAVmed Inc. (CPWY.) PAVmed Inc. (EQUR) PAVmed Inc. (ECIA) PAVmed Inc. (FMS) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED INSTRUMENTS Sector: Medical CUSIP: 70387R502 SIC: 3841 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/26 Next Expected EPS Date: 08/13/26 Share - Related Items Shares Outstanding: 1.00 Most Recent Split Date: 1.00 (0.03:1) Beta: 0.64 Market Capitalization: $6.36 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.80 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-3.19 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/13/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 0.30 Price/Cash Flow: - Price / Sales: 74.85 EPS Growth vs. Year Ago Period: -6.32% vs. Previous Quarter: -241.22% Sales Growth vs. Year Ago Period: 175.00% vs. Previous Quarter: -57.69% ROE 03/31/26 - -146.19 12/31/25 - -242.99 09/30/25 - -754.98 ROA 03/31/26 - -18.39 12/31/25 - -17.25 09/30/25 - -19.87 Current Ratio 03/31/26 - 2.02 12/31/25 - 0.17 09/30/25 - 0.40 Quick Ratio 03/31/26 - 2.02 12/31/25 - 0.17 09/30/25 - 0.40 Operating Margin 03/31/26 - -8,987.06 12/31/25 - -10,545.07 09/30/25 - -28,337.93 Net Margin 03/31/26 - -21,914.12 12/31/25 - 564.79 09/30/25 - 10,672.42 Pre-Tax Margin 03/31/26 - -26,065.88 12/31/25 - -3,477.47 09/30/25 - 4,931.03 Book Value 03/31/26 - 21.32 12/31/25 - -2.42 09/30/25 - -1.65 Inventory Turnover 03/31/26 - - 12/31/25 - - 09/30/25 - - Debt-to-Equity 03/31/26 - 0.70 12/31/25 - - 09/30/25 - - Debt-to-Capital 03/31/26 - 37.35 12/31/25 - 0.00 09/30/25 - 12.64

Powered by Zacks Investment Research ©